Cellino is using AI and machine learning to scale production of stem cell therapies
TechCrunch
SEPTEMBER 22, 2021
Instead, human cells being used now in these clinical trials are mostly being made by hand by scientists who are looking at cells and evaluating — using their many years of training and expertise — which cells are low quality and need to be removed. — could eventually democratize access to cell therapies.
Let's personalize your content